Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ZURAMPIC

LESINURAD

Standard Dose
200MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Discontinued
Summary

Approval overview ZURAMPIC is listed in Drugs@FDA under application 207988 (NDA).

Review priority: UNKNOWN Marketing status: Discontinued Active ingredient LESINURAD Form and strength TABLET;ORAL - 200MG Sponsor IRONWOOD PHARMS INC Submission history Latest submission status date: 2016-08-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZURAMPIC is listed in Drugs@FDA under application 207988 (NDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient LESINURAD Form and strength TABLET;ORAL - 200MG Sponsor IRONWOOD PHARMS INC Submission history Latest submission status date: 2016-08-04 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.